CHA Bundang Medical Centre; CHA university

Seongnam 13520

0 studies enrolling now · 3 studies all time

What they study most

Crohn Disease, Ulcerative Colitis

Studies at this site

• Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 — Stopped early
• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed